相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: A systematic review
Aunchalee Jaroenlapnopparat et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
The role of hepatitis B virus core-related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen-negative patients
Pao-Yuan Huang et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment
Muye Xia et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America
Marc G. Ghany et al.
HEPATOLOGY (2021)
HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation
Yandi Xie et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL
Tzu-Ning Tseng et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B
Rong Fan et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
Yao-Chun Hsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
Barbara Testoni et al.
JOURNAL OF HEPATOLOGY (2019)
Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA
En-Qiang Chen et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L. -Y. Mak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Serum HBV pgRNA as a clinical marker for cccDNA activity
Katja Giersch et al.
JOURNAL OF HEPATOLOGY (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
Jie Wang et al.
JOURNAL OF HEPATOLOGY (2016)
Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B
H. Chi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection
Chien-Hung Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal
GUT (2015)
Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
Wai-Kay Seto et al.
GUT (2015)
Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B
W. -K. Seto et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients
Masataka Tsuge et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely
Stephane Chevaliez et al.
JOURNAL OF HEPATOLOGY (2013)
High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
Kevin T. Chaung et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
分享论文
